The Genome as Commons
By Tom Athanasiou and Marcy Darnovsky,
WorldWatch
| 07. 01. 2002
Through all the trials and tribulations of human history what binds us in the end is our common humanity
July/August 2002
The atmosphere. The oceans and fresh waters. The land itself, and the fruits and grains our forebears bred and cultivated upon it. The broadcast spectrum. The attention spans of our children.
Does such a list adequately evoke "the commons," and the stakes we face in trying to save it—both for itself and as the foundation of our common future? Or must we add yet another, more shocking example? Perhaps we must put the human genome itself on this endangered commons list, and note that if this genetic commons too is lost to partition and privatization, if it too becomes the privilege of the affluent, then none of us on either side of the divide can be sure of retaining the "humanity" we like to think we've achieved.
The biotech boosters, of course, don't see things this way. Many of them insist that any conceivable application of human genetic engineering is essential to medical progress, and that the possibilities, no matter how speculative, trump all other considerations. Thus they shrug off the likely outcome of embryo cloning—that it will...
Related Articles
Sir Francis Galton, 1890s, by Eveleen Myers (née Tennant)
npg.org
Public Domain via Wikipedia
As has been discussed in recent issues of Biopolitical Times (1, 2), there are, increasingly, companies that claim to be selling parents better babies by selecting the “best” embryos. These services don’t come cheap – think $50,000, or even more, for embryo testing, plus perhaps as much again for IVF and concomitant services. To most of us, that is extremely expensive...
By Aaron Ginn, The Washington Post | 09.12.2025
Earlier this year, I had dinner in D.C. with Jensen Huang, the president and chief executive of Nvidia. At one point, he said something that struck me: “Why is everyone here so negative?”
He wasn’t referring to the economy...
By Kevin Roose, The New York Times | 09.12.2025
The first time I met Eliezer Yudkowsky, he said there was a 99.5 percent chance that A.I. was going to kill me.
I didn’t take it personally. Mr. Yudkowsky, 46, is the founder of the Machine Intelligence Research Institute, a...
By Roni Caryn Rabin, The New York Times | 08.25.2025
Scientists have dreamed for centuries about using animal organs to treat ailing humans. In recent years, those efforts have begun to bear fruit: Researchers have begun transplanting the hearts and kidneys of genetically modified pigs into patients, with varying degrees...